Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Epigallocatechin gallate induces an up-regulation of LDL receptor accompanied by a reduction of PCSK9 via the annexin A2-independent pathway in HepG2 cells
Authors
Keywords
-
Journal
MOLECULAR NUTRITION & FOOD RESEARCH
Volume 61, Issue 8, Pages 1600836
Publisher
Wiley
Online
2017-02-09
DOI
10.1002/mnfr.201600836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The Hypercholesterolemia-Risk Gene SORT1 Facilitates PCSK9 Secretion
- (2014) Camilla Gustafsen et al. Cell Metabolism
- Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9
- (2014) Kévin Ly et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Curcumin enhances cell-surface LDLR level and promotes LDL uptake through downregulation of PCSK9 gene expression in HepG2 cells
- (2014) Mi-Hsueh Tai et al. MOLECULAR NUTRITION & FOOD RESEARCH
- Quercetin-3-glucoside increases low-density lipoprotein receptor (LDLR) expression, attenuates proprotein convertase subtilisin/kexin 9 (PCSK9) secretion, and stimulates LDL uptake by Huh7 human hepatocytes in culture
- (2014) Majambu Mbikay et al. FEBS Open Bio
- SEC24A deficiency lowers plasma cholesterol through reduced PCSK9 secretion
- (2013) Xiao-Wei Chen et al. eLife
- PCSK9 Inhibition
- (2012) Robert A. Vogel JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Quercetin Up-regulates LDL Receptor Expression in HepG2 Cells
- (2012) Jiyoung Moon et al. PHYTOTHERAPY RESEARCH
- Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation
- (2012) Nabil G. Seidah et al. PLoS One
- Resveratrol increases the expression and activity of the low density lipoprotein receptor in hepatocytes by the proteolytic activation of the sterol regulatory element-binding proteins
- (2011) Takuya Yashiro et al. ATHEROSCLEROSIS
- The role of the annexin A2 heterotetramer in vascular fibrinolysis
- (2011) P. A. Madureira et al. BLOOD
- Epigallocatechin gallate changes mRNA expression level of genes involved in cholesterol metabolism in hepatocytes
- (2011) Tsuyoshi Goto et al. BRITISH JOURNAL OF NUTRITION
- Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells
- (2011) Aiqin Cao et al. JOURNAL OF LIPID RESEARCH
- The Influence of PCSK9 Polymorphisms on Serum Low-Density Lipoprotein Cholesterol and Risk of Atherosclerosis
- (2010) Jean Davignon et al. Current Atherosclerosis Reports
- High-dose atorvastatin causes a rapid sustained increase in human serum PCSK9 and disrupts its correlation with LDL cholesterol
- (2010) Greg Welder et al. JOURNAL OF LIPID RESEARCH
- Hepatocyte Nuclear Factor 1α Plays a Critical Role inPCSK9Gene Transcription and Regulation by the Natural Hypocholesterolemic Compound Berberine
- (2009) Hai Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels
- (2008) Gaétan Mayer et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started